Latest News about IMGN
Recent news which mentions IMGN
From InvestorPlace
3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List
February 06, 2024
From InvestorPlace
7 Russell 2000 Stocks to Buy for the Next Bull Run: February 2024
February 06, 2024
From InvestorPlace
AbbVie Lifts Long-Term Outlook For New Immunology Drugs, Even As Q4 Revenue and Profit Fall
February 02, 2024
From Benzinga
AbbVie's Transformational 2023, Analyst Anticipates Growth in 2024 Amid Competitive Pressures
January 29, 2024
From Benzinga
7 Dividend Aristocrats That Will Pay You for Years to Come
January 22, 2024
From InvestorPlace
Cramer Says This Major Healthcare Stock Is 'Ridiculously Cheap And Doing So Many Great Things'
January 08, 2024
From Benzinga
Is AbbVie Stock a Buy Now?
January 07, 2024
From Motley Fool
3 Biotech Stocks Set for Breakthroughs in 2024
January 02, 2024
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
January 02, 2024
From Benzinga
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
December 29, 2023
From Benzinga
AbbVie's Recent ImmunoGen Acquisition Looks Brilliant: Here's Why
December 26, 2023
From Motley Fool
3 Stocks at the Forefront of Medical Innovation
December 25, 2023
From InvestorPlace
The 7 Most Undervalued Growth Stocks to Buy in December
December 13, 2023
From InvestorPlace
From Motley Fool
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 11, 2023
From Benzinga
The 3 Best Cheap Stocks to Buy in December
December 10, 2023
From InvestorPlace
AbbVie Just Announced 2 Big Acquisitions: Is This Dividend King a No-Brainer Buy Right Now?
December 10, 2023
From Motley Fool
Market Movers: Why Big Players Are Investing Millions in These 3 Stocks
December 08, 2023
From InvestorPlace
From Motley Fool
AbbVie's New $9B Neuroscience Space Deal Might Attract FTC Scrutiny, Analyst Signals
December 07, 2023
From Benzinga
Is AbbVie Stock a Buy Now?
December 07, 2023
From Motley Fool
Small Cap, Big Potential: 3 Russell 2000 Stocks to Watch
December 06, 2023
From InvestorPlace
ImmunoGen, AbbVie's $10B Deal Comes At 'Right Time' Analyst Says In Downgrade Note
December 04, 2023
From Benzinga
From Benzinga
Why Abbvie Stock Popped Today
November 30, 2023
From Motley Fool
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.